In conclusion, pancreatic islet cell hyperplasia and co‐secretion of insulin (in addition to somatostatin) from tumour cells, respectively, have been characterized as completely distinct mechanisms of hypoglycaemia at the functional and morphological level in these two patients with malignant somatostatinomas. Here, INS is linked to neoplasm.